Daniel Dolan

Insider Reports History

Entity
Individual
Location
C/O Nabriva Therapeutics Plc, 1000 Continental Drive, Suite 600, King Of Prussia, PA
Signature
/s/ J. Christopher Naftzger, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Dolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Chief Financial Officer Stock Appreciation Right 83.2K Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Phantom Shares 41.6K Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Restricted Stock Units 0 Aug 11, 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Share Options 0 Aug 11, 2022 Direct

Insider Reports Filed by Daniel Dolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBRV Nabriva Therapeutics plc Aug 11, 2022 4 $0 4 Aug 15, 2022 Chief Financial Officer
NBRV Nabriva Therapeutics plc Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Financial Officer